Navigation Links
Surgery for early stage prostate cancer is better than waiting

In a research report done by Swedish scientists its said that it is better// to go for surgery while in early stage of prostate cancer than to wait and see if the disease progresses.

Surgery for treating prostate cancer, also known as prostatectomy, is a common procedure. The researchers had conducted he study to see if prostatectomy done in early stages of prostate cancer benefits the patients more than watching and waiting the cancer in the prostate gland to develop before going for the surgery.

Researchers are of the opinion that watching the patient in the early stages of prostate cancer and waiting for it to spread before conducting prostatectomy may not be much beneficial to the patients in terms of mortality and disease being spread to other parts of the body.

The results of the study, reported in the latest edition of New England Journal of Medicine, suggests that prostatectomy done in the early stages of cancer increases the rate of survival of the patients below 65 years of age by 40%. The rate of spread of cancer from the target cells to other locations, also known as metastasis, gets reduced by 44% when surgery is performed early. Although after a follow up period of ten years, early prostatectomy does not seem to be much beneficial in reducing the rate of mortality by a big margin, this procedure is substantially more advantageous in reducing the spread of the disease. , prostatectomy, prostate cancer, metastasis, rate of mortality, early stage, rate of survival
'"/>




Page: 1

Related medicine news :

1. Bypass Heart Surgery Performed Without General Anesthesia
2. Indian Prime Minister has successful Knee Replacement Surgery
3. Surgery made simple
4. Surgery a safety in senility
5. Breast Cancer Surgery Causes Psychological problems
6. Radiofrequency Energy Cooks Tumors Without Surgery
7. Heart Surgery Is Getting Safer for the Old
8. Surgery-Rigged pulley helps patients
9. Blood Vessel Surgery Safe for Diabetics
10. Ulcer Surgery connected to danger of Pancreatic Cancer
11. Surgery beneficial in Menieres disease
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/28/2016)... ... April 28, 2016 , ... Sanford Health’s work in cellular ... of researchers and leaders from Sanford Health were selected to participate in the ... Impact ” and receive the 2016 Pontifical Key Innovation Award at the Vatican. ...
(Date:4/28/2016)... ... 2016 , ... CastCoverz!, America’s #1 trusted brand for cast ... waterproof cast protector . As the largest one-stop, orthopedic shop, CastCoverz! offers ... night, weatherproof and waterproof covers for most orthopedic devices, including but not limited ...
(Date:4/28/2016)... (PRWEB) , ... April 28, ... ... Standards Consortium (CDISC) announces today the open availability of a new CDISC ... and catalogs for registering clinical trials. This innovative standard will make it ...
(Date:4/28/2016)... (PRWEB) , ... April 28, 2016 , ... ... and the Campaign for Tobacco-Free Kids, a leading force in the fight to ... federal, state and local policies that can help reduce tobacco use. The initiative ...
(Date:4/28/2016)... ... 28, 2016 , ... In 2011, TIME magazine named Herr the “Leader of ... technology that marries human physiology with electromechanics. He continues that work as Director of ... of BionX , a leader in the field of prosthetic devices. , After ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)... , April 28, 2016  ValGenesis, Inc., ... Management Solutions (VLMS) today announced that a ... for sufferers of chronic kidney failure has ... manage their corporate validation process. The global ... software solution to manage their validation processes ...
(Date:4/27/2016)... -- Hologic, Inc. (Nasdaq: HOLX ) announced ... second quarter ended March 26, 2016.  GAAP diluted ... and non-GAAP diluted EPS of $0.47 increased 14.6%.  ... reported basis, and 6.3% on a constant currency ... quarter, highlighted by 14.6% growth in non-GAAP EPS," ...
(Date:4/27/2016)... , April 27, 2016   ... 42% Growth in Recurring Consumable Sales  Clinical ... Mauna Kea Technologies (Euronext: MKEA, OTCQX: MKEAY) inventor of ... its sales for the first quarter ended March 31, ... the execution of its commercial strategy. First ...
Breaking Medicine Technology: